[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Efficacy And Safety Of Padsevonil As Adjunctive Treatment Of Focal-Onset Seizures In Adult Subjects With Drug-Resistant Epilepsy.

What is the purpose of the study?

Observe the effectivness of Padsevonil to treat patients with focal-onset drug resistant epilepsy.

Upstate Institutional Review Board (IRB) Number:

1370414

Study/Protocol ID:

EP0092

Study Phase:

Phase 3

Patient Age Group:

Adults

Principal Investigator:

Robert L Beach

What is involved if I participate?

  • How long is the study?
    27 Weeks
  • Is transportation provided or reimbursed?
    Yes
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Physical and Neurological Examination, ECG, Blood Tests, Pregnancy Test,

Where will the study take place?

Clinical Research Unit on the first floor of the IHP building.

ClinicalTrials.Gov ID:

NCT1370414

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Muhammad M Iqbal
Phone: 315-464-1814
Email: iqbalmuh@upstate.edu

Return to Previous Page || Search Again

Top